The German Centre for Cardiovascular Research is funding three clinical trials to improve treatment for Corona patients with cardiovascular complications.
Prof. Stefanie Dimmeler will start as the new spokesperson of the Board of Directors at the German Center for Cardiovascular Research (DZHK). She takes office in December 2020. Dimmeler succeeds Prof. Thomas Eschenhagen, who will retire from the Board of Directors at the end of...
Whether patients suffer from acutely or chronically narrowed coronary vessels – quantitative imaging techniques are indispensable when it comes to detecting and treating circulatory disorders of the heart muscle or preventing them in time. An interdisciplinary team, in which...
When the heart valve between the aorta and the left ventricle is narrowed, i.e. aortic valve stenosis is present, different genes are active in men than in women. Scientists of the German Centre for Cardiovascular Research (DZHK) at Charité – Universitätsmedizin Berlin have...
Age is one of the biggest risk factors for cardiovascular diseases. Scientists at the German Centre for Cardiovascular Research (DZHK) have now investigated what happens deep in the heart when it ages. They have studied the cells from thousands of old and young hearts to compare...
Scientists from the German Centre for Cardiovascular Research (DZHK) at the partner site Heidelberg University Hospital have discovered how a small molecule in the heart – responsible for protecting the heart’s pumping action - is produced in mouse heart muscle cells. This...
Without patients participating in clinical trials, we could make no progress in medicine. Nowadays, all treatment decisions are made based on controlled clinical data. The German Centre for Cardiovascular Research (DZHK) has published a video for patients to increase their trust...
Sudden cardiac death causes great suffering and raises many questions. It is therefore a focus of research at the German Centre for Cardiovascular Research. Professor Axel Bauer, University Hospital Munich and Medical University Innsbruck, explains who is at risk of sudden...
Twelve European partners have joined forces to tackle one of the biggest challenges in cardiovascular medicine: the regeneration of lost heart muscle cells. The partners will together receive €8 million from the European Horizon 2020 programme for the REANIMA project. The DZHK...
After a heart attack or unstable angina pectoris, antiplatelet treatment with prasugrel is better for patients than with ticagrelor. This is the unexpected result of ISAR-REACT 5, an industry-independent study funded by the German Centre for Cardiovascular Research (DZHK) and the...
